AlzeCure Pharma to present at Redeye Neurology Day

PUBT · 2d ago
AlzeCure Pharma to present at Redeye Neurology Day
  • AlzeCure Pharma will attend Redeye Neurology Day in Stockholm on Oct. 15, 2026.
  • CEO Martin Jönsson is scheduled to present at 11:15 CEST, including an update on outlicensing agreements with Eli Lilly, QuantumCell.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzeCure Pharma AB published the original content used to generate this news brief on October 07, 2026, and is solely responsible for the information contained therein.